Glycosylation-dependent cleavage of the human β₁-adrenoceptor

J Mol Cell Cardiol. 2021 May:154:154-155. doi: 10.1016/j.yjmcc.2021.03.002. Epub 2021 Mar 9.

Authors

Andrea Ahles¹, Stefan Engelhardt²

Affiliations

¹ Institute of Pharmacology and Toxicology, Technische Universität München (TUM), Munich 80802, Germany.
² Institute of Pharmacology and Toxicology, Technische Universität München (TUM), Munich 80802, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich 80802, Germany. Electronic address: stefan.engelhardt@tum.de.

PMID: 33711343
DOI: 10.1016/j.yjmcc.2021.03.002

No abstract available

Publication types

Editorial
Comment

MeSH terms

ADAM17 Protein
Down-Regulation
Glycosylation
Humans
Myocytes, Cardiac* / metabolism
Oxidation-Reduction
Receptors, Adrenergic, beta-1* / genetics
Receptors, Adrenergic, beta-1* / metabolism

Substances

Receptors, Adrenergic, beta-1
ADAM17 Protein
ADAM17 protein, human